News

All news articles, press releases, and other news-related information posted by NISS.

Communicating Statistics to the Media: Highs and Lows During the Pandemic Described

News Category:
News
The current pandemic crisis is notable for the vast amount of traffic in official and unofficial information and claims.  Who better to offer some personal insights into the challenges of trying to bring some illumination to the statistics about the pandemic than Sir David Spiegelhalter.... more

Ingram Olkin Forum Deliberates Bayes and Frequentist Approaches to Rescuing Disrupted Trials

News Category:
News
When a study is disrupted by COVID-19, investigators are faced with the question of what to do next. Should they simply analyze the current data and reach a conclusion? If the trial is re-started with a new recruitment phase, is it permissible to change the target sample size or modify the... more

Winners Announced for the 2020-2021 SAID in Graphics Data Visualization Contest!

News Category:
News
[Please Note: The 2020-2021 competition has come to a close and the judges have made their decisions.  The winners of the first contest can be found below. Information about the Spring 2022 competition can be found following the link below:  The Spring 2022 NISS SAID in... more

Lu Chen and Phil Kott NASS Awards of Excellence Recipients 2021

News Category:
Press Release
NASS held its annual award ceremony this past Wednesday, April 21, 2021.  There were multiple individuals from NISS that were recognized for their exceptional efforts. Two NASS Circle Awards included NISS researchers. Farm Labor Team - Circle Award Nathan Cruze (NISS Associate... more

NISS-Merck Meet-up Discusses Open-Source Software in Pharma (April 21, 2021)

News Category:
News
Typically, in NISS-Merck meetups you find yourself immersed in detailed discussions about the statistical issues involved in drug/vaccine development and/or clinical trials.  This time around the focus seemed to shift from applications to implications.  If you use increasingly popular... more

Flying the Plane While Improving It – Learning from COVID Patient Data in Close to Real Time (April 19, 2021)

News Category:
News
Moderator Karen Bandeen-Roche, (Johns Hopkins University) opened the session by introducing both of the speakers.  The first speaker was Brian Garibaldi, (Johns Hopkins) Associate Professor of Medicine in the Division of Pulmonary Critical Care Medicine, and Director of the Johns Hopkins... more

Preparing For a Position in Non-clinical Biostatistics in the Pharmaceutical Industry: What You Need to Know! (April 16, 2021)

News Category:
News
This session involved members of the Student and Young Professionals Outreach Committee of the Non-clinical Biostatisticians Working Group (NCBWG), BioPharmaceutical Section of the American Statistical Association (ASA).  They included Tom Bradstreet (Director at Bristol-Myers Squibb), Oluyemi... more

Pandemics, Poverty and Public Health: A Conversation with Jim Yong Kim (April 2, 2021)

News Category:
News
Unlike a keynote address in a large hall, and because of Jim Yong Kim’s (Former President of the World Bank) direct involvement in events combatting infectious disease, and his personable, storytelling approach, Zoom framed Dr. Kim as though we were all sitting in his living room and he was talking... more

What Should Be In the Modern Statisticians Toolkit? (March 31, 2021)

News Category:
News
The session was organized and hosted by both the Academic Affiliates Committee and NISS Graduate Student Network.  Several earlier webinars focused on how to get a job in academia, industry or government but this one took a different angle.  If someone is preparing for a position in any... more

Ingram Olkin Forum Explores Methods to Cope with Information Loss and the Use of Auxiliary Sources of Data (March 29, 2021)

News Category:
News
[Please Note: The program for this Ingram Olkin Forum on Unplanned Clinical Trial Disruptions is available at:  Session Five. In some studies, disrupted by COVID-19, continued follow-up of existing patients and recruitment of new patients has not been possible, leading to smaller sample... more

Pages